Evidence map›Paper›PMID 33569629›Full record

ArticleActa neuropathologica2021

Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter.

Carmen Picon, Anusha Jayaraman, Rachel James, Catriona Beck, Patricia Gallego, Maarten E Witte, Jack van Horssen, Nicholas D Mazarakis, Richard Reynolds

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Mechanisms, regulation and clinical relevance of necroptosis.Nature reviews. Molecular cell biology · 2026
    Review
  3. Review
  4. Immune-mediated excitotoxicity in brain disorders.Nature reviews. Immunology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Cell death in multiple sclerosis.Cell death and differentiation · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Role of CYLD in brain physiology and pathology.Journal of molecular medicine (Berlin, Germany) · 2025
    Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Carmen PiconDivision of Neuroscience, Department of Brain Sciences, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, W12 0NN, UK.
Anusha JayaramanCentre for Molecular Neuropathology, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Rachel JamesDivision of Neuroscience, Department of Brain Sciences, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, W12 0NN, UK.
Catriona BeckDivision of Neuroscience, Department of Brain Sciences, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, W12 0NN, UK.
Patricia GallegoDivision of Neuroscience, Department of Brain Sciences, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, W12 0NN, UK.
Maarten E WitteDepartment of Pathology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands.
Jack van HorssenDepartment of Pathology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands.
Nicholas D MazarakisDivision of Neuroscience, Department of Brain Sciences, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, W12 0NN, UK.
Richard ReynoldsDivision of Neuroscience, Department of Brain Sciences, Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, London, W12 0NN, UK. r.reynolds@imperial.ac.uk.ORCID 0000-0003-4622-4694
Hammersmith Hospital · GBAmsterdam Neuroscience · NLNanyang Technological University · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sustained exposure to pro-inflammatory cytokines in the leptomeninges is thought to play a major role in the pathogenetic mechanisms leading to cortical pathology in multiple sclerosis (MS). Although the molecular mechanisms underlying neurodegeneration in the grey matter remain unclear, several lines of evidence suggest a prominent role for tumour necrosis factor (TNF). Using cortical grey matter tissue blocks from post-mortem brains from 28 secondary progressive MS subjects and ten non-neurological controls, we describe an increase in expression of multiple steps in the TNF/TNF receptor 1 signaling pathway leading to necroptosis, including the key proteins TNFR1, FADD, RIPK1, RIPK3 and MLKL. Activation of this pathway was indicated by the phosphorylation of RIPK3 and MLKL and the formation of protein oligomers characteristic of necrosomes. In contrast, caspase-8 dependent apoptotic signaling was decreased. Upregulation of necroptotic signaling occurred predominantly in macroneurons in cortical layers II-III, with little expression in other cell types. The presence of activated necroptotic proteins in neurons was increased in MS cases with prominent meningeal inflammation, with a 30-fold increase in phosphoMLKL+ neurons in layers I-III. The density of phosphoMLKL+ neurons correlated inversely with age at death, age at progression and disease duration. In vivo induction of chronically elevated TNF and INFγ levels in the CSF in a rat model via lentiviral transduction in the meninges, triggered inflammation and neurodegeneration in the underlying cortical grey matter that was associated with increased neuronal expression of TNFR1 and activated necroptotic signaling proteins. Exposure of cultured primary rat cortical neurons to TNF induced necroptosis when apoptosis was inhibited. Our data suggest that neurons in the MS cortex are dying via TNF/TNFR1 stimulated necroptosis rather than apoptosis, possibly initiated in part by chronic meningeal inflammation. Neuronal necroptosis represents a pathogenetic mechanism that is amenable to therapeutic intervention at several points in the signaling pathway.

Indexed as

AdultAgedAnimalsCerebral CortexFemaleGray MatterHumansMaleMiddle AgedMultiple Sclerosis, Chronic ProgressiveNecroptosisNeuronsRatsReceptors, Tumor Necrosis FactorSignal TransductionTumor Necrosis Factor-alphaReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaApoptosisCytokinesMeningesNecroptosisNeurodegeneration

Identifiers

PMID33569629
PMCPMC7952371
OpenAlexW3126474793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.